Circulating osteogenic precursor cells

Critical Reviews in Eukaryotic Gene Expression

Volumn 20, Issue 2, 2010, Pages 171-180

  Pignolo, Robert J ^a   Shore, Eileen M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Circulating osteogenic precursor cells; CXCR4; Heterotopic ossification; Monocytes; SDF 1

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; OSTEONECTIN; OSTEOPONTIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL ISOLATION; CELL POPULATION; CIRCULATING OSTEOGENIC PRECURSOR CELL; CORONARY ARTERY ATHEROSCLEROSIS; FRACTURE; FRACTURE HEALING; HEMATOPOIETIC SYSTEM; HETEROTOPIC OSSIFICATION; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSSIFYING MYOSITIS; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PUBERTY; RHEUMATOID ARTHRITIS; STEM CELL; UMBILICAL CORD BLOOD; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; OSTEOBLASTS; OSTEOGENESIS; STEM CELLS;

EID: 79952279756     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v20.i2.70     Document Type: Article

References (61)

1. Huss R, Lange C, Weissinger EM, Kolb HJTK. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) A3 hematopoietic stem cell cloAne4s with mesenchymal stem cell characteristics. Stem Cells. 2000;18:252-60.
2. Zvaifler NJ, Marinova-Mutafchieva L, Adams G Edwards CJ, Moss J, Burger JA, Maini RN. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Research. 2000;2(6):477-88.
3. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001;153(5):1133-40.
4. Rosada C, Justesen J, Melsvik D, Ebbesen P, Kas-sem M. The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int. 2003;72(2):135-42.
5. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol. 2004;36:585-97.
6. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchy-mal cell differentiation. J Leukoc Biol. 2003;74(5):833-45.
7. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103(5):1669-75.
8. Kuznetsov SA, Mankani MH, Leet AI, Ziran N, Gronthos S, Robey PG. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. 2007;25(7):1830-9.
9. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med. 2005;352(19):1959-66.
10. Suda RK, Billings PC, Egan KP, Kim JH, McCarrick-Walmsley R, Glaser DL, Porter DL, Shore EM, Pignolo RJ. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009;27(9):2209-19.
11. Choi YH, Burdick MD, Strieter RM. Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int J Biochem. Cell Biol 2010;42(5):662-71.
12. Valenti MT, Dalle Carbonare L, Donatelli L, Bertoldo F, Zanatta M, Lo Cascio V. Gene expression analysis in os-teoblastic differentiation from peripheral blood mesenchy-mal stem cells. Bone. 2008;43(6):1084-92.
13. Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 2003;75(5):679-85.
14. Eghbali-Fatourechi GZ, Modder UI, Charatcharoenwittha-ya N, Sanyal A, Undale AH, Clowes JA, Tarara JE, Khosla S. Characterization of circulating osteoblast lineage cells in humans. Bone. 2007;40(5):1370-7.
15. Hutson EL, Boyer S, Genever PG. Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. Tissue Eng. 2005;11(9-10):1407-20.
16. Long MW, Robinson JA, Ashcraft EA, Mann KG. Regulation of human bone marrow-derived osteopro-genitor cells by osteogenic growth factors. J Clin Invest. 1995;95(2):881-7.
17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Hor-witz E. Minimal criteria for defining multipotent mesen-chymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7.
18. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A. 2003;100(5):2426-31.
19. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun. 2007;354(2):453-8.
20. Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype. Br J Haematol. 2003;122(3):506-17.
21. Olmsted-Davis EA, Gugala Z, Camargo F, Gannon FH, Jackson K, Kienstra KA, Shine HD, Lindsey RW, Hirschi KK, Goodell MA, Brenner MK, Davis AR. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003;100(26):15877-82.
22. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. Hematopoietic cells and osteo-blasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A. 2004;101(32):11761-6.
23. Buring K. On the origin of cells in heterotopic bone formation. Clin Orthop. 1975;(110):293-301.
24. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504-8.
25. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166(12):7556-62.
26. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998;160(1):419-25.
27. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A. 1997;94(12):6307-12.
28. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1(1):71-81.
29. Quan TE, Cowper S, Sou-Pan W, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol. 2004;36:598-606.
30. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci. 2003;60(7):1342-50.
31. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002;82(9):1183-92.
32. Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cu-tan Pathol. 1997;24:65-9.
33. Aiba S, Tabata N, Ohtani H, Tagami H. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol. 1994;130:593-7.
34. Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswa-my A. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 2002;440:128-33.
35. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch. 2002;440:298-303.
36. Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S, Tomita T, Ochi T. Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol. 2001;70:413-21.
37. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114(3):438-46.
38. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008;26(2):165-75.
39. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by CXCR4/ SDF-1 pathway. Stem Cells. 2008;26:223-34.
40. Kaplan FS, Smith RM. Fibrodysplasia ossificans progres-siva (FOP). J Bone Miner Res. 1997;12(5):855.
41. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gil-lessen-Kaesbach G, Hoover-Fong J, Köster B, Pauli RM, Reardon W, Zaidi SA, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30(3):379-90.
42. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525-7.
43. Kaplan FS, Tabas JA, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossifi-cans progressiva. An endochondral process. J Bone Joint Surg Am. 1993;75(2):220-30.
44. Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification? J Pathol. 2003;201(1):141-8.
45. Pignolo RJ, Foley KL. Nonhereditary heterotopic ossification: Implications for injury, arthropathy, and aging. Clin Rev Bone Min Metab. 2005;3:261-6.
46. Neal B, Gray H, MacMahon S, Dunn L. Incidence of het-erotopic bone formation after major hip surgery. ANZ J Surg. 2002;72(11):808-21.
47. Neal B. Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J Surg. 2003;73(6):422-6.
48. Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg. 2002;10(6):409-16.
49. Schneider DJ, Moulton MJ, Singapuri K, Chinchilli V, Deol GS, Krenitsky G, Pellegrini VD Jr. The Frank Stinch-field Award. Inhibition of heterotopic ossification with radiation therapy in an animal model. Clin Orthop Relat Res. 1998;(355):35-46.
50. Ritter MA, Vaughan RB. Ectopic ossification after total hip replacement. J Bone Joint Surg Am. 1977;59:345-51.
51. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103(11):1522-8.
52. Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol. 2008;52(16):1314-25.
53. Mc Gonagle D, Gibbon W, O'Connor P, Blythe D, Wake-field R, Green M, Veale D, Emery P. A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis. Rheumatology (Oxford). 1999;38(4):329-31.
54. Undale A, Srinivasan B, Drake M, McCready L, Atkinson E, Peterson J, Riggs BL, Amin S, Moedder UI, Khosla S. Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women. Bone. 2010;47(1):83-92.
55. Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009;60(11):3356-65.
56. Kan L, Liu Y, McGuire TL, Berger DM, Awatramani RB, Dymecki SM, Kessler JA. Dysregulation of local stem/ progenitor cells as a common cellular mechanism for het-erotopic ossification. Stem Cells. 2009;27:150-6.
57. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10(8):858-64.
58. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angio-genesis and invasion. Cancer Cell. 2008;13(3):206-20.
59. Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemo-tactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A. 1992;89(24):11740-4.
60. Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gu-gala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schu-mara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR. Hypoxic adipocytes pattern early hetero-topic bone formation. Am J Pathol. 2007;170(2):620-32.
61. Kaplan FS, Groppe J, Pignolo RJ, Shore EM. Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci. 2007;1116:113-33.